Ubidecarenone


Concise Prescribing Info
Indications/Uses
Listed in Dosage.
Dosage/Direction for Use
Adult: PO Heart failure 50-150 mg/day in 2-3 divided doses. Angina pectrois 150-600 mg/day in divided doses.
Administration
Should be taken with food.
Special Precautions
Avoid intense exercise during ubidecarenone therapy.
Adverse Reactions
Gastric discomfort, anorexia, diarrhoea, nausea, skin rash, heart burn. Increase in LFT with doses >300 mg/day.
Drug Interactions
Decreased serum levels with statins. Possible decrease in INR with warfarin.
ATC Classification
C01EB09 - ubidecarenone ; Belongs to the class of other cardiac preparations.
Disclaimer: This information is independently developed by CIMS based on ubidecarenone from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to CIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, CIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2021 CIMS. All rights reserved. Powered by CIMSAsia.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in